Clicky

Vir Biotechnology, Inc.(VIR) News

Date Title
May 12 Vir Biotechnology to Participate in Bank of America Securities 2025 Healthcare Conference
May 9 Vir Biotechnology Announces Preliminary 24-Week Post-End of Treatment Data for Tobevibart and Elebsiran Combinations in Chronic Hepatitis B From the MARCH Study
May 8 Q1 2025 Vir Biotechnology Inc Earnings Call
May 8 Vir Biotechnology Inc (VIR) Q1 2025 Earnings Call Highlights: Navigating Challenges with ...
May 7 Vir Biotechnology, Inc. (VIR) Reports Q1 Loss, Lags Revenue Estimates
May 7 Vir Biotechnology Provides Corporate Update and Reports First Quarter 2025 Financial Results
Apr 9 Vir Biotechnology, Inc. (VIR): Among Stocks Under $10 that Will Triple
Mar 13 Vir Biotechnology Enrolls First Patient in Phase 3 ECLIPSE Registrational Program for Chronic Hepatitis Delta
Mar 1 Analysts Have Lowered Expectations For Vir Biotechnology, Inc. (NASDAQ:VIR) After Its Latest Results
Feb 27 Q4 2024 Vir Biotechnology Inc Earnings Call
Feb 27 Vir Biotechnology Inc (VIR) Q4 2024 Earnings Call Highlights: Strategic Advances Amid Financial ...
Feb 26 Vir Biotechnology, Inc. (VIR) Reports Q4 Loss, Lags Revenue Estimates
Feb 26 Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2024 Financial Results
Feb 19 Vir Biotechnology to Participate in TD Cowen 45th Annual Health Care Conference
Feb 12 Vir Biotechnology to Provide Corporate Update and Report Fourth Quarter and Full Year 2024 Financial Results on February 26, 2025
Jan 10 Morgan Stanley Doubles Vir Biotechnology Price Forecast - Here's Why
Jan 9 VIR Stock Up on Early Safety & Efficacy Data on Two Cancer Candidates
Jan 9 Vir Biotechnology Reports Promising Trial Results for Cancer Therapies
Jan 8 Vir Biotechnology Catapults 58% On Promising Results In Cancer Treatment
Jan 8 Vir Biotechnology Announces Encouraging Safety and Efficacy Data in Ongoing Dose Escalation Trials for Dual Masked T-Cell Engagers VIR-5818 in Solid Tumors and VIR-5500 in mCRPC